MAGROLIMAB: 80 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
80
Total FAERS Reports
18 (22.5%)
Deaths Reported
52
Hospitalizations
80
As Primary/Secondary Suspect
8
Life-Threatening
First Report: 20190401 · Latest Report: 20240108
What Are the Most Common MAGROLIMAB Side Effects?
#1 Most Reported
Neutropenia
12 reports (15.0%)
#2 Most Reported
Febrile neutropenia
11 reports (13.8%)
#3 Most Reported
Hallucination
10 reports (12.5%)
All MAGROLIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 12 | 15.0% | 0 | 10 |
| Febrile neutropenia | 11 | 13.8% | 3 | 10 |
| Hallucination | 10 | 12.5% | 0 | 0 |
| Catheter site infection | 9 | 11.3% | 0 | 9 |
| Corynebacterium bacteraemia | 9 | 11.3% | 0 | 9 |
| Anaemia | 8 | 10.0% | 0 | 5 |
| Infusion related reaction | 8 | 10.0% | 0 | 4 |
| Fall | 7 | 8.8% | 0 | 7 |
| Nausea | 7 | 8.8% | 0 | 6 |
| Disease progression | 6 | 7.5% | 4 | 5 |
| Drug ineffective | 5 | 6.3% | 3 | 2 |
| Treatment failure | 5 | 6.3% | 4 | 0 |
Who Reports MAGROLIMAB Side Effects? Age & Gender Data
Gender: 52.9% female, 47.1% male. Average age: 61.0 years. Most reports from: US. View detailed demographics →
Is MAGROLIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2019 | 5 | 0 | 4 |
| 2020 | 5 | 1 | 4 |
| 2021 | 2 | 1 | 1 |
| 2022 | 13 | 4 | 11 |
| 2023 | 33 | 6 | 21 |
| 2024 | 1 | 0 | 1 |
What Is MAGROLIMAB Used For?
| Indication | Reports |
|---|---|
| Acute myeloid leukaemia | 40 |
| Myelodysplastic syndrome | 15 |
Official FDA Label for MAGROLIMAB
Official prescribing information from the FDA-approved drug label.